Quinazoline-4-one AMPA antagonists for the treatment of dyskinesias associated with dopamine agonist therapy


Ontology type: sgo:Patent     


Patent Info

DATE

2001-05-02T00:00

AUTHORS

CHENARD, BERTRAND LEO , GREENAMYRE, JOHN TIMOTHY , MENNITI, FRANK SAMUEL , WELCH, WILLARD MCKOWAN, JR.

ABSTRACT

The invention relates to a method of treating dyskinesias associated with dopamine agonist therapy in a mammal which comprises administering to said mammal an effective amount of an antagonist of the AMPA receptor. Dopamine agonist therapy, as referred to in the present invention, is generally used in the treatment of a central nervous system disorder such as Parkinson's disease. More... »

Related SciGraph Publications

  • 1991-09. Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-Dopa in models of Parkinson's disease in JOURNAL OF NEURAL TRANSMISSION: PARKINSON'S DISEASE A AND DEMENTIA SECTION
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3120", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "name": "CHENARD, BERTRAND LEO", 
            "type": "Person"
          }, 
          {
            "name": "GREENAMYRE, JOHN TIMOTHY", 
            "type": "Person"
          }, 
          {
            "name": "MENNITI, FRANK SAMUEL", 
            "type": "Person"
          }, 
          {
            "name": "WELCH, WILLARD MCKOWAN, JR.", 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/bf02259538", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1008710569", 
              "https://doi.org/10.1007/bf02259538"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf02259538", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1008710569", 
              "https://doi.org/10.1007/bf02259538"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/ddr.430070307", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1034954158"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2001-05-02T00:00", 
        "description": "

    The invention relates to a method of treating dyskinesias associated with dopamine\nagonist therapy in a mammal which comprises administering to said mammal an effective\namount of an antagonist of the AMPA receptor. Dopamine agonist therapy, as referred to in\nthe present invention, is generally used in the treatment of a central nervous system disorder\nsuch as Parkinson's disease.

    ", "id": "sg:patent.EP-0900567-A3", "keywords": [ "antagonist", "dyskinesia", "dopamine agonist", "invention", "method", "AMPA receptor", "central nervous system disorder", "Parkinson's", "disease" ], "name": "Quinazoline-4-one AMPA antagonists for the treatment of dyskinesias associated with dopamine agonist therapy", "recipient": [ { "id": "https://www.grid.ac/institutes/grid.410513.2", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/EP-0900567-A3" ], "sdDataset": "patents", "sdDatePublished": "2019-04-18T10:24", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-uberresearch-data-patents-target-20190320-rc/data/sn-export/402f166718b70575fb5d4ffe01f064d1/0000100128-0000352499/json_export_02209.jsonl", "type": "Patent" } ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.EP-0900567-A3'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.EP-0900567-A3'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.EP-0900567-A3'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.EP-0900567-A3'


     

    This table displays all metadata directly associated to this object as RDF triples.

    50 TRIPLES      15 PREDICATES      25 URIs      17 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:patent.EP-0900567-A3 schema:about anzsrc-for:3120
    2 schema:author Nec90fb496cc74a0e87d9deb2179cfa96
    3 schema:citation sg:pub.10.1007/bf02259538
    4 https://doi.org/10.1002/ddr.430070307
    5 schema:datePublished 2001-05-02T00:00
    6 schema:description <p>The invention relates to a method of treating dyskinesias associated with dopamine agonist therapy in a mammal which comprises administering to said mammal an effective amount of an antagonist of the AMPA receptor. Dopamine agonist therapy, as referred to in the present invention, is generally used in the treatment of a central nervous system disorder such as Parkinson's disease.</p>
    7 schema:keywords AMPA receptor
    8 Parkinson's
    9 antagonist
    10 central nervous system disorder
    11 disease
    12 dopamine agonist
    13 dyskinesia
    14 invention
    15 method
    16 schema:name Quinazoline-4-one AMPA antagonists for the treatment of dyskinesias associated with dopamine agonist therapy
    17 schema:recipient https://www.grid.ac/institutes/grid.410513.2
    18 schema:sameAs https://app.dimensions.ai/details/patent/EP-0900567-A3
    19 schema:sdDatePublished 2019-04-18T10:24
    20 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    21 schema:sdPublisher N9f1e0f37a5b940a89726935036af6913
    22 sgo:license sg:explorer/license/
    23 sgo:sdDataset patents
    24 rdf:type sgo:Patent
    25 N0a742a3489d348b880f2fd8162e87928 schema:name WELCH, WILLARD MCKOWAN, JR.
    26 rdf:type schema:Person
    27 N14750904ca474a25a7ae04eee20202c7 schema:name GREENAMYRE, JOHN TIMOTHY
    28 rdf:type schema:Person
    29 N16e2bea8bc0a4261840ee154f97aa9e2 rdf:first N8dc921fd47924e31bf8c5036c931c39d
    30 rdf:rest N4d2afa2854b54c9bab2a9410311d1d36
    31 N4d2afa2854b54c9bab2a9410311d1d36 rdf:first N0a742a3489d348b880f2fd8162e87928
    32 rdf:rest rdf:nil
    33 N7fbfb936a47843349edf3a2469e8624a schema:name CHENARD, BERTRAND LEO
    34 rdf:type schema:Person
    35 N8dc921fd47924e31bf8c5036c931c39d schema:name MENNITI, FRANK SAMUEL
    36 rdf:type schema:Person
    37 N9f1e0f37a5b940a89726935036af6913 schema:name Springer Nature - SN SciGraph project
    38 rdf:type schema:Organization
    39 Nafe57a56c75841c0b534cf9f413f79cd rdf:first N14750904ca474a25a7ae04eee20202c7
    40 rdf:rest N16e2bea8bc0a4261840ee154f97aa9e2
    41 Nec90fb496cc74a0e87d9deb2179cfa96 rdf:first N7fbfb936a47843349edf3a2469e8624a
    42 rdf:rest Nafe57a56c75841c0b534cf9f413f79cd
    43 anzsrc-for:3120 schema:inDefinedTermSet anzsrc-for:
    44 rdf:type schema:DefinedTerm
    45 sg:pub.10.1007/bf02259538 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008710569
    46 https://doi.org/10.1007/bf02259538
    47 rdf:type schema:CreativeWork
    48 https://doi.org/10.1002/ddr.430070307 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034954158
    49 rdf:type schema:CreativeWork
    50 https://www.grid.ac/institutes/grid.410513.2 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...